-
1
-
-
0026439199
-
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD
-
Canellos GP, Anderson JR, Propert KJ, et al. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med. 1992;327:1478-1484.
-
(1992)
N Engl J Med
, vol.327
, pp. 1478-1484
-
-
Canellos, G.P.1
Anderson, J.R.2
Propert, K.J.3
-
2
-
-
0037007678
-
Long-term follow-up of Hodgkin's disease trial
-
Canellos GP, Niedzwiecki D. Long-term follow-up of Hodgkin's disease trial. N Engl J Med. 2002;346:1417-1418.
-
(2002)
N Engl J Med
, vol.346
, pp. 1417-1418
-
-
Canellos, G.P.1
Niedzwiecki, D.2
-
3
-
-
0037441660
-
Advanced Hodgkin's disease: ABVD is better, yet is not good enough&excl
-
Diehl V. Advanced Hodgkin's disease: ABVD is better, yet is not good enough! J Clin Oncol. 2003;21:583-585.
-
(2003)
J Clin Oncol
, vol.21
, pp. 583-585
-
-
Diehl, V.1
-
4
-
-
0032548107
-
A prognostic score for advanced Hodgkin's disease. International prognostic factors project on advanced Hodgkin's disease
-
Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease [see comments]. N Engl J Med. 1998;339:1506-1514.
-
(1998)
N Engl J Med
, vol.339
, pp. 1506-1514
-
-
Hasenclever, D.1
Diehl, V.2
-
5
-
-
0036467658
-
Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: Mature results of a prospective clinical trial
-
Horning SJ, Hoppe RT, Breslin S, Bartlett NL, Brown BW, Rosenberg SA. Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: mature results of a prospective clinical trial. J Clin Oncol. 2002;20:630-637.
-
(2002)
J Clin Oncol
, vol.20
, pp. 630-637
-
-
Horning, S.J.1
Hoppe, R.T.2
Breslin, S.3
Bartlett, N.L.4
Brown, B.W.5
Rosenberg, S.A.6
-
6
-
-
0032422646
-
BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: Interim report from a trial of the German Hodgkin's Lymphoma Study Group
-
Diehl V, Franklin J, Hasenclever D, et al. BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group. J Clin Oncol. 1998;16:3810-3821.
-
(1998)
J Clin Oncol
, vol.16
, pp. 3810-3821
-
-
Diehl, V.1
Franklin, J.2
Hasenclever, D.3
-
7
-
-
0033650534
-
Autologous hematopoietic cell transplantation in Hodgkin's disease
-
Johnston LJ, Horning SJ. Autologous hematopoietic cell transplantation in Hodgkin's disease. Biol Blood Marrow Transplant. 2000;6:289-300.
-
(2000)
Biol Blood Marrow Transplant
, vol.6
, pp. 289-300
-
-
Johnston, L.J.1
Horning, S.J.2
-
8
-
-
0035281922
-
Autologous stem-cell transplantation for Hodgkin's disease: Results and prognostic factors in 494 patients from the Grupo Espanol de Linfomas/Transplante Autologo de Medula Osea Spanish Cooperative Group
-
Sureda A, Arranz R, Iriondo A, et al. Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Espanol de Linfomas/Transplante Autologo de Medula Osea Spanish Cooperative Group. J Clin Oncol. 2001;19:1395-1404.
-
(2001)
J Clin Oncol
, vol.19
, pp. 1395-1404
-
-
Sureda, A.1
Arranz, R.2
Iriondo, A.3
-
9
-
-
0037105618
-
Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: Long-term risks and risk factors
-
Ng AK, Bernardo MV, Weller E, et al. Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood. 2002;100:1989-1996.
-
(2002)
Blood
, vol.100
, pp. 1989-1996
-
-
Ng, A.K.1
Bernardo, M.V.2
Weller, E.3
-
10
-
-
0030870485
-
Gemcitabine. A review of its pharmacology and clinical potential in non-small cell lung cancer and pancreatic cancer
-
Noble S, Goa KL. Gemcitabine. A review of its pharmacology and clinical potential in non-small cell lung cancer and pancreatic cancer. Drugs. 1997;54:447-472.
-
(1997)
Drugs
, vol.54
, pp. 447-472
-
-
Noble, S.1
Goa, K.L.2
-
12
-
-
0033782490
-
Value of gemcitabine treatment in heavily pretreated Hodgkin's disease patients
-
Zinzani PL, Bendandi M, Stefoni V, et al. Value of gemcitabine treatment in heavily pretreated Hodgkin's disease patients. Haematologica. 2000;85:926-929.
-
(2000)
Haematologica
, vol.85
, pp. 926-929
-
-
Zinzani, P.L.1
Bendandi, M.2
Stefoni, V.3
-
13
-
-
0033932803
-
Gemcitabine in the treatment of refractory Hodgkin's disease: Results of a multicenter Phase II study
-
Santoro A, Bredenfeld H, Devizzi L, et al. Gemcitabine in the treatment of refractory Hodgkin's disease: results of a multicenter Phase II study. J Clin Oncol. 2000;18:2615-2619.
-
(2000)
J Clin Oncol
, vol.18
, pp. 2615-2619
-
-
Santoro, A.1
Bredenfeld, H.2
Devizzi, L.3
-
14
-
-
0015405388
-
5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of lymphoma
-
Frei E III, Luce JK, Talley RW, Vaitkevicius VK, Wilson HE. 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of lymphoma. Cancer Chemother Rep. 1972;56:667-670.
-
(1972)
Cancer Chemother Rep
, vol.56
, pp. 667-670
-
-
Frei E. III1
Luce, J.K.2
Talley, R.W.3
Vaitkevicius, V.K.4
Wilson, H.E.5
-
15
-
-
0024422603
-
Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting
-
published erratum appears in J Clin Oncol 1990;8:1602
-
Lister TA, Crowther D, Sutcliffe SB, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting [published erratum appears in J Clin Oncol. 1990;8:1602] [see comments]. J Clin Oncol. 1989;7:1630-1636.
-
(1989)
J Clin Oncol
, vol.7
, pp. 1630-1636
-
-
Lister, T.A.1
Crowther, D.2
Sutcliffe, S.B.3
-
16
-
-
0025117688
-
Fatal pulmonary failure complicating high-dose cytosine arabinoside therapy in acute leukemia
-
Andersson BS, Luna MA, Yee C, Hui KK, Keating MJ, McCredie KB. Fatal pulmonary failure complicating high-dose cytosine arabinoside therapy in acute leukemia. Cancer. 1990;65:1079-1084.
-
(1990)
Cancer
, vol.65
, pp. 1079-1084
-
-
Andersson, B.S.1
Luna, M.A.2
Yee, C.3
Hui, K.K.4
Keating, M.J.5
McCredie, K.B.6
-
17
-
-
0030996855
-
Fatal pulmonary toxicity resulting from treatment with gemcitabine
-
Pavlakis N, Bell DR, Millward MJ, Levi JA. Fatal pulmonary toxicity resulting from treatment with gemcitabine. Cancer. 1997;80:286-291.
-
(1997)
Cancer
, vol.80
, pp. 286-291
-
-
Pavlakis, N.1
Bell, D.R.2
Millward, M.J.3
Levi, J.A.4
-
21
-
-
0036164677
-
Gemcitabine-induced pulmonary toxicity: Case report and review of the literature
-
Gupta N, Ahmed I, Steinberg H, Patel D, Nissel-Horowitz S, Mehrotra B. Gemcitabine-induced pulmonary toxicity: case report and review of the literature. Am J Clin Oncol. 2002;25:96-100.
-
(2002)
Am J Clin Oncol
, vol.25
, pp. 96-100
-
-
Gupta, N.1
Ahmed, I.2
Steinberg, H.3
Patel, D.4
Nissel-Horowitz, S.5
Mehrotra, B.6
-
23
-
-
4243708016
-
BAGCOPP - A follow up report on a pilot study with a modified BEACOPP regimen showing unexpected acute toxicity in patients with advanced-stage Hodgkin's disease
-
Bredenfeld H, Fries S, Meisner M, et al. BAGCOPP - a follow up report on a pilot study with a modified BEACOPP regimen showing unexpected acute toxicity in patients with advanced-stage Hodgkin's disease [abstract]. Blood. 2002;100:295b.
-
(2002)
Blood
, vol.100
-
-
Bredenfeld, H.1
Fries, S.2
Meisner, M.3
-
24
-
-
0026850260
-
Bleomycin pulmonary toxicity: Current status and future directions
-
Comis RL. Bleomycin pulmonary toxicity: current status and future directions. Semin Oncol. 1992;19(2 Suppl 5): 64-70.
-
(1992)
Semin Oncol
, vol.19
, Issue.2 SUPPL. 5
, pp. 64-70
-
-
Comis, R.L.1
-
26
-
-
0037441857
-
Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: Report of an intergroup trial
-
Duggan DB, Petroni GR, Johnson JL, et al. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial. J Clin Oncol. 2003;21:607-614.
-
(2003)
J Clin Oncol
, vol.21
, pp. 607-614
-
-
Duggan, D.B.1
Petroni, G.R.2
Johnson, J.L.3
-
27
-
-
79960971262
-
Results of a prospective randomized trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) alone vs. ABVD + radiation therapy for early stage non-bulky Hodgkin's disease
-
Straus DJ, Yahalom J, Zelenetz AD, et al. Results of a prospective randomized trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) alone vs. ABVD + radiation therapy for early stage non-bulky Hodgkin's disease [abstract]. Blood. 2001;98:769a.
-
(2001)
Blood
, vol.98
-
-
Straus, D.J.1
Yahalom, J.2
Zelenetz, A.D.3
|